E-Book, Englisch, 408 Seiten
Watson Modulation of Sleep by Obesity, Diabetes, Age, and Diet
1. Auflage 2014
ISBN: 978-0-12-420240-5
Verlag: Elsevier Science & Techn.
Format: EPUB
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
E-Book, Englisch, 408 Seiten
ISBN: 978-0-12-420240-5
Verlag: Elsevier Science & Techn.
Format: EPUB
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
Sleep disorder is a rampant problem in the US, with over 40 million Americans currently diagnosed according to the NIH. There is a clear association between sleep disorder and a wide range of other human disorders -performance deficiencies, psychiatric illnesses, heart disease, obesity and more - but in spite of this there is not yet a convenient overview on the market detailing the impact of obesity, age, diabetes and diet on sleep duration and attendant health outcomes. This volume focuses on the interaction between sleep and these factors, with special attention being paid to the potential for neurological modulation of sleep via diet. The volume aid readers in understanding the role each of these factors plays in sleep architecture and its regulation by circadian biology and neurology. - Aids in understanding the impact of age, diet, obesity and disease on sleep - Offers focus on neurological changes that affect metabolism - Explores diabetes induced sleep problems - Aid to understanding the multifactorial causes of age-related sleep dysfunction - Addresses selected studies of nutraceuticals affecting sleep for potential application clinically - Discusses major impact on sleep disorders by caffeine and alcohol
Autoren/Hrsg.
Weitere Infos & Material
1;Front Cover;1
2;Modulation of Sleep by
Obesity, Diabetes, Age,
and Diet;4
3;Copyright;5
4;Contents;6
5;Contributors;14
6;Acknowledgments;18
7;Part I - Mechanisms of Sleep
Deprivation and General
Dietary Therapies;20
7.1;Chapter 1 - Diet, Age, and Sleep in Invertebrate Model Organisms;22
7.1.1;INTRODUCTION;22
7.1.2;HOW DO WE KNOW THAT THE ANIMAL IS SLEEPING?;22
7.1.3;DIFFERENT WAYS TO EVALUATE SLEEP;23
7.1.4;CORRELATIONS BETWEEN ECOLOGICAL NICHE AND SLEEP BEHAVIOR;23
7.1.5;EFFECTS OF DIET ON SLEEP;24
7.1.6;EFFECTS OF DISEASE AND AGE ON SLEEP;26
7.1.7;EFFECTS OF SLEEP ON FEEDING AND DISEASE;27
7.1.8;SUMMARY;27
7.1.9;REFERENCES;27
7.2;Chapter 2 - The Role of Sleep in the Control of Feeding Behavior;30
7.2.1;INTRODUCTION;30
7.2.2;EFFECT OF SLEEP RESTRICTION ON HUNGER AND FOOD INTAKE;31
7.2.3;NEUROENDOCRINE CONTROL OF FOOD INTAKE AND SLEEP DURATION;31
7.2.4;SLEEP RESTRICTION AND FOOD CHOICE;33
7.2.5;CONCLUSIONS;34
7.2.6;ACKNOWLEDGMENTS;34
7.2.7;REFERENCES;34
7.3;Chapter 3 - Diagnosis and Treatment of Shift Work Disorder;36
7.3.1;INTRODUCTION;36
7.3.2;CIRCADIAN RHYTHMS;36
7.3.3;SYMPTOMS AND DIAGNOSIS OF SWD;37
7.3.4;DIFFERENTIAL DIAGNOSIS OF SWD;38
7.3.5;CONSEQUENCES OF SWD;38
7.3.6;TREATMENT;38
7.3.7;SUMMARY;41
7.3.8;REFERENCES;41
7.4;Chapter 4 - Normal Sleep and Its Neurophysiological Regulation;44
7.4.1;NORMAL SLEEP PATTERN OVER THE NIGHT;44
7.4.2;SLEEP IS REGULATED BY CIRCADIAN AND HOMEOSTATIC MECHANISMS;46
7.4.3;SLEEP AND AGING;47
7.4.4;NEUROPHYSIOLOGY OF SLEEP;47
7.4.5;SLEEP MECHANISMS AND THE CIRCADIAN CLOCK;50
7.4.6;CONCLUSION;50
7.4.7;REFERENCES;50
7.5;Chapter 5 - The 1-2-3s of Pediatric Sleep Disorders;52
7.5.1;INTRODUCTION;52
7.5.2;NORMAL SLEEP PHYSIOLOGY;52
7.5.3;INSUFFICIENT SLEEP SYNDROME;53
7.5.4;SLEEP HISTORY/PHYSICAL EXAMINATION;53
7.5.5;DIAGNOSTIC TOOLS FOR PEDIATRIC SLEEP DISORDERS;54
7.5.6;BEHAVIORAL INSOMNIA OF CHILDHOOD;54
7.5.7;PARASOMNIAS;55
7.5.8;CIRCADIAN RHYTHM DISORDERS—DELAYED SLEEP PHASE SYNDROME;56
7.5.9;RHYTHMIC MOVEMENT DISORDERS;57
7.5.10;PERIODIC LIMB MOVEMENT DISORDER;57
7.5.11;SLEEP DISORDERED BREATHING;57
7.5.12;HYPERSOMNIA/NARCOLEPSY;58
7.5.13;SUMMARY;59
7.5.14;REFERENCES;59
7.6;Chapter 6 - Sleep Disturbances, Body Mass Index, and Eating Behavior;62
7.6.1;INTRODUCTION;62
7.6.2;STUDIES EXPLORING THE EFFECT OF SLEEP DIFFICULTIES ON THE MODULATION OF EATING DISTURBANCES/BMI;63
7.6.3;STUDIES EXPLORING EATING BEHAVIOR DISTURBANCES/BMI EFFECT ON MODULATION OF SLEEP DIFFICULTIES;64
7.6.4;LONGITUDINAL STUDIES IN GENERAL POPULATION SUBJECTS EXPLORING THE BIDIRECTIONAL ASSOCIATION BETWEEN SLEEP AND EATING DISTURBANCE...;69
7.6.5;BODY MASS INDEX VERSUS EATING BEHAVIOR DISTURBANCES ASSOCIATIONS WITH SLEEP;70
7.6.6;POTENTIAL MECHANISMS OF ASSOCIATION;71
7.6.7;DISCUSSION;74
7.6.8;REFERENCES;76
8;Part II - Obesity and Sleep Apnea;80
8.1;Chapter 7 - Neurocognitive Functions in Patients with Obstructive Sleep Apnea Hypopnea Syndrome;82
8.1.1;OBSTRUCTIVE SLEEP APNEA HYPOPNEA SYNDROME;82
8.1.2;NEUROCOGNITIVE FUNCTIONS;82
8.1.3;NEUROCOGNITIVE FUNCTIONS IN UNTREATED OSA PATIENTS;83
8.1.4;NEUROCOGNITIVE FUNCTIONS BEFORE AND AFTER CPAP TREATMENT;83
8.1.5;NEUROCOGNITIVE FUNCTION IN OSA PATIENTS WHO RECEIVED DIFFERENT MODES OF TREATMENT;84
8.1.6;NEUROCOGNITIVE FUNCTIONS AFTER CPAP WITHDRAWAL;85
8.1.7;DOES TREATING SLEEP APNEA IMPROVE NEUROCOGNITIVE FUNCTION?;85
8.1.8;CONCLUSION;86
8.1.9;REFERENCES;86
8.2;Chapter 8 - Adipose Tissue in Sleep Apnea: Effects of Hypoxia and Inflammation;88
8.2.1;INTRODUCTION;88
8.2.2;HYPOXIA AND INFLAMMATION IN ADIPOSE TISSUE;88
8.2.3;EFFECTS OF INTERMITTENT OR CONTINUOUS HYPOXIA;91
8.2.4;CLINICAL IMPLICATIONS;92
8.2.5;CONCLUSIONS;93
8.2.6;REFERENCES;93
8.3;Chapter 9 - Exercise, Diet, and Obese Adolescents: Association with Sleep Deprivation;96
8.3.1;SLEEP HABITS IN ADOLESCENTS;96
8.3.2;RELATIONSHIP BETWEEN SLEEP HABITS AND OBESITY;97
8.3.3;ENERGY INTAKE, SLEEP, AND OBESITY;98
8.3.4;ENERGY EXPENDITURE, SLEEP, AND OBESITY;99
8.3.5;CONCLUSION;100
8.3.6;REFERENCES;100
8.4;Chapter 10 - Sleep and Hypoxemia in Adults;104
8.4.1;REFERENCES;108
8.5;Chapter 11 - Obesity Hypoventilation Syndrome;110
8.5.1;INTRODUCTION;110
8.5.2;MECHANISMS UNDERLYING THE DEVELOPMENT OF OHS;110
8.5.3;CLINICAL CONSEQUENCES OF OHS;114
8.5.4;TREATMENT MODALITIES AND OUTCOMES;114
8.5.5;CONCLUSION;116
8.5.6;REFERENCES;117
8.6;Chapter 12 - Sleep, Sexual Function, and Testosterone;120
8.6.1;PITUITARY–GONADAL AXIS;120
8.6.2;PITUITARY–GONADAL AXIS DURING SLEEP IN HEALTHY MALES;121
8.6.3;SEXUAL DYSFUNCTION;121
8.6.4;ROLE OF SLEEP IN SEXUAL DYSFUNCTION;123
8.6.5;CONCLUSION;125
8.6.6;REFERENCES;125
8.7;Chapter 13 - The Malignant Obesity Hypoventilation Syndrome;128
8.7.1;INTRODUCTION;128
8.7.2;PATHOPHYSIOLOGY;128
8.7.3;CLINICAL PRESENTATION AND DIAGNOSTIC APPROACH;130
8.7.4;MANAGEMENT;132
8.7.5;REFERENCES;133
8.8;Chapter 14 - Obesity, Inflammation, and Obstructive Sleep Apnea: Exercise as Therapy;136
8.8.1;INTRODUCTION;136
8.8.2;OBESITY AS A MAIN RISK FACTOR FOR OSA;136
8.8.3;THE VICIOUS CYCLE BETWEEN OBESITY AND OSA;137
8.8.4;INFLAMMATION: A COMMON LINK BETWEEN OBESITY AND OSA;138
8.8.5;OSA AND OBESITY-RELATED DISORDERS;139
8.8.6;EFFECTS OF EXERCISES AND NUTRITION ON THE TREATMENT OF OBESITY AND OSA;140
8.8.7;CONCLUSION AND FUTURE DIRECTIONS;142
8.8.8;REFERENCES;142
8.9;Chapter 15 - Obstructive Sleep Apnea in Normal-Weight and Obese Patients;146
8.9.1;WHAT CAUSES OSAS IN NORMAL-WEIGHT PATIENTS?;146
8.9.2;WHAT CAUSES OSAS IN OBESE PATIENTS?;147
8.9.3;DIFFERENCES IN THE NATURE OF OSAS IN NORMAL-WEIGHT AND OBESE PATIENTS;148
8.9.4;CONSEQUENCES OF OSAS IN OBESE AND NORMAL-WEIGHT PATIENTS;149
8.9.5;THERAPY OF OSAS IN OBESE AND NONOBESE PATIENTS;150
8.9.6;ACKNOWLEDGMENT;152
8.9.7;REFERENCES;152
9;Part III - Metabolic Syndrome and Sleep
Deprivation;156
9.1;Chapter 16 - Obstructive Sleep Apnea and the Metabolic Syndrome: Clinical Profiles and Relationships;158
9.1.1;TERMINOLOGY OF SLEEP APNEA;158
9.1.2;THE METABOLIC SYNDROME;158
9.1.3;PRIMARY SNORING;159
9.1.4;AIRWAY PHYSIOLOGY IN OBESITY;159
9.1.5;PULMONARY VASCULATURE;161
9.1.6;THE OBESITY HYPERVENTILATION SYNDROME;161
9.1.7;THE OVERLAP SYNDROME: COPD AND OSA;161
9.1.8;CARDIOVASCULAR MORBIDITY;162
9.1.9;HYPERTENSION;162
9.1.10;ARRHYTHMIAS;163
9.1.11;CONUNDRUMS;164
9.1.12;CONCLUSIONS;166
9.1.13;REFERENCES;166
9.2;Chapter 17 - Circadian Misalignment and Metabolic Consequences: Shiftwork and Altered Meal Times;174
9.2.1;OVERVIEW;174
9.2.2;MISALIGNED CLOCKS AND PHYSIOLOGICAL CONSEQUENCES—MECHANISMS;175
9.2.3;MISALIGNED CLOCKS AND PHYSIOLOGICAL CONSEQUENCES—EVIDENCE;178
9.2.4;SUMMARY;181
9.2.5;REFERENCES;181
9.3;Chapter 18 - Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea;184
9.3.1;INTRODUCTION;184
9.3.2;THE METABOLIC SYNDROME: THE “ACTORS”;184
9.3.3;HYPERTENSION;185
9.3.4;OBESITY;186
9.3.5;SYMPATHETIC ACTIVATION IN THE METABOLIC SYNDROME;186
9.3.6;THE HYPERADRENERGIC TONE IN SLEEP APNEA SYNDROME;187
9.3.7;MECHANISMS RESPONSIBLE FOR THE SYMPATHETIC ABNORMALITIES;189
9.3.8;SYMPATHETIC ACTIVATION AND CARDIOVASCULAR RISK;190
9.3.9;THERAPEUTIC IMPLICATIONS;190
9.3.10;REFERENCES;192
9.4;Chapter 19 - Obstructive Sleep Apnea and the Metabolic Syndrome: Pathophysiological and Clinical Evidence;196
9.4.1;INTRODUCTION;196
9.4.2;EPIDEMIOLOGY OF OSAS;196
9.4.3;OSAS AND CARDIOVASCULAR DISEASES;196
9.4.4;DEFINITION AND CLINICAL PRESENTATION OF METS;197
9.4.5;OSAS AND METS;197
9.4.6;OSAS AND CENTRAL OBESITY;198
9.4.7;OSAS AND ARTERIAL HYPERTENSION;198
9.4.8;OSAS, INSULIN RESISTANCE AND DIABETES;199
9.4.9;OSAS AND ATHEROGENIC DYSLIPIDEMIA;199
9.4.10;OSAS AND INFLAMMATION;199
9.4.11;OSAS AND OXIDATIVE STRESS;199
9.4.12;OSAS AND ENDOTHELIAL DYSFUNCTION;200
9.4.13;CPAP AND METS;200
9.4.14;CONCLUSIONS;201
9.4.15;REFERENCES;201
9.5;Chapter 20 - Sleep Deprivation and Metabolic Syndrome;204
9.5.1;INTRODUCTION;204
9.5.2;SD AND HYPERTENSION;204
9.5.3;SLEEP LOSS AND GLUCOSE METABOLISM;206
9.5.4;SD AND OBESITY;208
9.5.5;CONCLUSIONS;209
9.5.6;REFERENCES;209
9.6;Chapter 21 - Excessive Daytime Sleepiness: Age, Sleep, Mood, and Metabolic Modulation;212
9.6.1;INTRODUCTION;212
9.6.2;DEFINITION;212
9.6.3;SLEEP;213
9.6.4;MOOD;214
9.6.5;METABOLISM;215
9.6.6;PUBLIC HEALTH AND CLINICAL IMPLICATIONS;217
9.6.7;REFERENCES;218
9.7;Chapter 22 - The Metabolic Role of Saturated and Monounsaturated Dietary Fatty Acids: Their Contribution to Obesity, Brain Activity, and Sleep Behavior;222
9.7.1;METABOLIC ABNORMALITIES DURING OBESITY;222
9.7.2;INSULIN ACTION IN THE BRAIN;223
9.7.3;BRAIN INSULIN RESISTANCE;223
9.7.4;FATTY ACID SIGNALING THROUGH RECEPTORS;223
9.7.5;IMPACT OF FAT ON GLUCOSE HOMEOSTASIS;224
9.7.6;FAT QUALITY CORRELATES WITH INSULIN SENSITIVITY;225
9.7.7;CONSEQUENCES OF IMPAIRED SLEEP BEHAVIOR ON METABOLISM;225
9.7.8;METABOLIC SLEEP DISTURBANCES;226
9.7.9;REFERENCES;227
10;Part IV - Sleep and Diabetes;230
10.1;Chapter 23 - Obstructive Sleep Apnea and Diabetic Microvascular Complications;232
10.1.1;INTRODUCTION;232
10.1.2;THE PATHOGENESIS OF DIABETIC MICROVASCULAR COMPLICATIONS;233
10.1.3;WHY MIGHT OSA CONTRIBUTE TO THE DEVELOPMENT AND PROGRESSION OF DIABETIC MICROVASCULAR COMPLICATIONS?;234
10.1.4;OSA AND DIABETIC MICROVASCULAR COMPLICATIONS;237
10.1.5;SUMMARY AND CONCLUSIONS;238
10.1.6;REFERENCES;238
10.2;Chapter 24 - Obstructive Sleep Apnea Increases Hemoglobin A1c Levels: Mechanisms and Consequences;244
10.2.1;INTRODUCTION;244
10.2.2;ASSOCIATION BETWEEN OSA SEVERITY AND HBA1C LEVELS IN OSA PATIENTS;244
10.2.3;ASSOCIATION BETWEEN OSA SEVERITY AND HBA1C LEVELS IN DIABETIC PATIENTS;245
10.2.4;EFFECT OF CPAP ON HBA1C LEVELS;246
10.2.5;MECHANISMS FOR THE ADVERSE EFFECT OF OSA ON GLUCOSE METABOLISM;248
10.2.6;CONCLUSIONS;248
10.2.7;REFERENCES;248
11;Part V - Aging and Sleep Deprivation;252
11.1;Chapter 25 - Restless Legs Syndrome (Willis–Ekbom Disease) and Gastrointestinal Diseases;254
11.1.1;INTRODUCTION;254
11.1.2;GENERAL DISCUSSION OF SMALL-INTESTINAL BACTERIAL OVERGROWTH;255
11.1.3;GASTROINTESTINAL DISEASES ASSOCIATED WITH RLS;256
11.1.4;DIETARY TRIGGERS FOR RLS AND FOR RLS ASSOCIATED WITH CELIAC DISEASE AND SIBO;259
11.1.5;CONCLUSIONS;259
11.1.6;REFERENCES;259
11.2;Chapter 26 - Relationship between Circadian Rhythms, Feeding, and Obesity;262
11.2.1;GENERAL INTRODUCTION;262
11.2.2;CIRCADIAN DISRUPTION AND OBESITY;264
11.2.3;TIMING OF FEEDING;267
11.2.4;SUMMARY;269
11.2.5;REFERENCES;269
11.3;Chapter 27 - The Effects of Nutrition on Sleep and Sleep Complaints among Elderly Persons;274
11.3.1;INTRODUCTION;274
11.3.2;MECHANISMS OF SLEEP;274
11.3.3;NUTRITION AND SLEEP PROBLEMS AMONG ELDERLY PERSONS;275
11.3.4;REFERENCES;280
11.4;Chapter 28 - Fragmented Sleep and Memory Consolidation;282
11.4.1;SLEEP ARCHITECTURE;282
11.4.2;DISORDERS OF SLEEP ARCHITECTURE;283
11.4.3;STUDYING SLEEP CONTINUITY;283
11.4.4;THE FUNCTIONS OF SLEEP;284
11.4.5;FUNCTIONAL OUTCOMES OF SLEEP FRAGMENTATION;285
11.4.6;SUMMARY;287
11.4.7;REFERENCES;287
11.5;Chapter 29 - Sleepiness at the Wheel and Countermeasures: Effects of Caffeine, Napping, and Blue Light;290
11.5.1;INTRODUCTION;290
11.5.2;LACK OF SLEEP AND ACCIDENTS;290
11.5.3;SHIFT WORK AND ACCIDENTS;291
11.5.4;COUNTERMEASURES;292
11.5.5;CONCLUSION;294
11.5.6;REFERENCES;294
11.6;Chapter 30 - Sleep Deprivation and Behavioral Risk-Taking;298
11.6.1;SIMPLE INATTENTION;299
11.6.2;LACK OF AWARENESS OF DEFICITS;299
11.6.3;REDUCED INHIBITORY CAPACITY;299
11.6.4;SUBJECTIVE RISK-TAKING PROPENSITY;300
11.6.5;BEHAVIORAL RISK-TAKING;301
11.6.6;CONCLUSIONS;304
11.6.7;REFERENCES;305
12;Part VI - Food, Nutrients, and Dietary
Supplements: Sleep Modulation;308
12.1;Chapter 31 - Relation between Magnesium Deficiency and Sleep Disorders and Associated Pathological Changes;310
12.1.1;INTRODUCTION;310
12.1.2;MAGNESIUM DEFICIENCY IN HUMANS;310
12.1.3;BIOCHEMICAL BASIS FOR MAGNESIUM AFFECTING SLEEP;311
12.1.4;MAGNESIUM DEFICIENCY AND SLEEP DISORDERS;312
12.1.5;SUMMARY/CONCLUSION;314
12.1.6;REFERENCES;314
12.2;Chapter 32 - Physical Activity and Sedentary Time in Sleep Apnea and Obesity;316
12.2.1;PHYSICAL ACTIVITY;316
12.2.2;PHYSICAL ACTIVITY IN SLEEP APNEA AND OBESITY;316
12.2.3;SEDENTARY TIME;317
12.2.4;CORRELATES OF PHYSICAL ACTIVITY AND SEDENTARY TIME;317
12.2.5;HEALTH BEHAVIOR CHANGE OF PHYSICAL ACTIVITY AND SEDENTARY TIME;318
12.2.6;SUMMARY;318
12.2.7;REFERENCES;318
12.3;Chapter 33 - Oxidative Stress in Sleep Apnea;322
12.3.1;SLEEP APNEA SYNDROME;322
12.3.2;OXIDATIVE STRESS;323
12.3.3;SAS AND OXIDATIVE STRESS;323
12.3.4;CLINICAL STUDIES ON OXIDATIVE STRESS IN SAS;324
12.3.5;THE EFFECTS OF CONTINUOUS POSITIVE AIRWAY PRESSURE ON OXIDATIVE STRESS;325
12.3.6;CONCLUSION;326
12.3.7;REFERENCES;326
13;Part VII - Alcohol and Sleep Dysfunction;330
13.1;Chapter 34 - Sleep in Fetal Alcohol Spectrum Disorders;332
13.1.1;INTRODUCTION;332
13.1.2;CHARACTERIZING SLEEP PROBLEMS IN CHILDREN WITH FETAL ALCOHOL SPECTRUM DISORDERS;332
13.1.3;CHARACTERIZING SLEEP DISRUPTION IN MODELS OF PRENATAL ALCOHOL EXPOSURE;333
13.1.4;MECHANISTIC LINKS BETWEEN PRENATAL ALCOHOL EXPOSURE AND SLEEP DIFFICULTIES;333
13.1.5;SLEEP PROBLEMS AND PSYCHOSOCIAL RISK;334
13.1.6;IMPACT OF SLEEP DIFFICULTIES ON DAYTIME FUNCTION;334
13.1.7;IMPACT OF SLEEP DIFFICULTIES ON CAREGIVER FUNCTION;335
13.1.8;CONCLUSION;335
13.1.9;REFERENCES;336
13.2;Chapter 35 - Adenosine and Glutamate in Neuroglial Interaction: Implications for Sleep Disorders and Alcoholism;340
13.2.1;INTRODUCTION;340
13.2.2;PURINERGIC REGULATION OF HOMEOSTATIC SLEEP BY ASTROCYTES;341
13.2.3;ADENOSINERGIC MODULATION OF CIRCADIAN RHYTHMS;341
13.2.4;LOW ADENOSINE TONE IN ALCOHOL WITHDRAWAL-INDUCED INSOMNIA;342
13.2.5;REGULATION OF ALCOHOL DRINKING BY ADENOSINE AND GLUTAMATE IN NEUROGLIAL INTERACTION;342
13.2.6;EAAT2 AS A TREATMENT TARGET FOR ALCOHOL USE DISORDERS;342
13.2.7;CONCLUSIONS;343
13.2.8;CONFLICT OF INTEREST;343
13.2.9;ACKNOWLEDGMENTS;343
13.2.10;REFERENCES;343
13.3;Chapter 36 - Sleep Quality and Risk of Alcohol Misuse;348
13.3.1;SLEEP AND ALCOHOL USE: ACUTE EFFECTS;348
13.3.2;SLEEP AND ALCOHOL USE: BEHAVIORAL RISKS;349
13.3.3;CONSIDERATIONS FOR FUTURE RESEARCH;351
13.3.4;REFERENCES;352
13.4;Chapter 37 - Sleep and Addictions: Linking Sleep Regulation with the Genesis of Addictive Behavior;356
13.4.1;INTRODUCTION;356
13.4.2;SLEEP PATTERNS;356
13.4.3;MECHANISMS OF ADDICTION;359
13.4.4;LINKING SLEEP AND SLEEP DIFFICULTY WITH ADDICTION PATHWAYS;361
13.4.5;SLEEP, PLASTICITY, AND ADDICTIONS.TYING IT ALL TOGETHER;362
13.4.6;CONCLUDING REMARKS;363
13.4.7;REFERENCES;363
13.5;Chapter 38 - Alcohol and Sleep-Disordered Breathing;368
13.5.1;INTRODUCTION;368
13.5.2;PATIENT-BASED STUDIES;368
13.5.3;POPULATION-BASED STUDIES;369
13.5.4;ALCOHOL CONSUMPTION AND SDB BY BMI SUBGROUPS;370
13.5.5;CONCLUSION;370
13.5.6;REFERENCES;370
13.6;Chapter 39 - Patterns of Alcohol Consumption and Sleep in Shiftworkers;372
13.6.1;SHIFTWORK, SLEEP, AND HEALTH;372
13.6.2;ALCOHOL AND HEALTH;373
13.6.3;ALCOHOL AND SLEEP;374
13.6.4;ALCOHOL AND SHIFTWORK;375
13.6.5;REFERENCES;380
14;Part VIII - Surgery;384
14.1;Chapter 40 - The Impact of Bariatric Surgery on Obstructive Sleep Apnea;386
14.1.1;OBSTRUCTIVE SLEEP APNEA: DEFINITION AND CLINICAL FEATURES;386
14.1.2;OBESITY AND SLEEP APNEA;387
14.1.3;BARIATRIC SURGERY: THE PRESENT STATE;388
14.1.4;IMPACT OF BARIATRIC SURGERY ON OBSTRUCTIVE SLEEP APNEA;390
14.1.5;THE KEY TO TREATING OBSTRUCTIVE SLEEP APNEA WITH BARIATRIC SURGERY;391
14.1.6;REFERENCES;392
14.2;Chapter 41 - Preoperative, Perioperative, and Postoperative Considerations in the Bariatric Surgery Patient with Sleep Apnea;394
14.2.1;OBESITY AND OBSTRUCTIVE SLEEP APNEA;394
14.2.2;PREOPERATIVE ASSESSMENT;395
14.2.3;PERIOPERATIVE CONSIDERATIONS;395
14.2.4;POSTOPERATIVE CONSIDERATIONS;396
14.2.5;EFFECT OF BARIATRIC SURGERY ON OSA;397
14.2.6;REFERENCES;398
15;Index;400
Contributors
Q.A. Altaf Centre of Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK Francesco Angelico, Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy Enrique Calvo Ayala, Division of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, VA, USA Siobhan Banks, Centre for Sleep Research, University of South Australia, Adelaide, SA, Australia Francesco Baratta, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy Kelly G. Baron, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA Maria Rosaria Bonsignore Dipartimento Biomedico di Medicina Interna e Specialistica (DiBiMIS), Università di Palermo, Palermo, Italy Istituto di Biomedicina e Immunologia Molecolare (IBIM), Consiglio Nazionale delle Ricerche (CNR), Palermo, Italy Susan L. Calhoun, Sleep Research & Treatment Center, Penn State Milton S. Hershey Medical Center, College of Medicine, Pennsylvania State University, Hershey, PA, USA Violeta Alejandra Castaño-Meneses, Clínica de Trastornos del Dormir, Departamento de Neurología y Psiquiatría, INCMNSZ, México City, México Alessandra Castrogiovanni, Dipartimento Biomedico di Medicina Interna e Specialistica (DiBiMIS), Università di Palermo, Palermo, Italy Peter Celec Institute of Molecular Biomedicine, Comenius University, Bratislava, Slovakia Center for Molecular Medicine, Slovak Academy of Sciences, Bratislava, Slovakia Institute of Pathophysiology, Comenius University, Bratislava, Slovakia Department of Molecular Biology, Comenius University, Bratislava, Slovakia Maida Lynn Chen, Division of Pulmonary and Sleep Medicine, University of Washington School of Medicine, Seattle Children’s Hospital, Seattle, WA, USA Alison Coates, Nutritional Physiology Research Centre, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia Flávia C. Corgosinho, Programa de Pós-Graduação em Nutrição, Universidade Federal de São Paulo, São Paulo, Brazil Renzhe Cui, Public Health, Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Suita-City, Osaka, Japan Ana R. Dâmaso, Programa de Pós-Graduação em Nutrição, Universidade Federal de São Paulo, São Paulo, Brazil Alessandra Danese, Department of Neurological, Neuropsychological, Morphological and Movement Sciences, University Hospital of Verona, Verona, Italy Maria Del Ben, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy Jillian Dorrian, Centre for Sleep Research, University of South Australia, Adelaide, SA, Australia Alfred Dreher, Department of Otorhinolaryngology, Ludwig-Maximilians-University, Munich Germany Dan Eisenberg, Department of Surgery, Stanford School of Medicine and Palo Alto VA Health Care System, Palo Alto, CA, USA Julio Fernandez-Mendoza, Sleep Research & Treatment Center, Penn State Milton S. Hershey Medical Center, College of Medicine, Pennsylvania State University, Hershey, PA, USA Marta Garaulet, Department of Physiology, University of Murcia, Murcia, Spain Guillermo García-Ramos, Departamento de Neurología y Psiquiatría, INCMNSZ, México City, México Purificación Gómez-Abellán, Department of Physiology, University of Murcia, Murcia, Spain Crystal Grant, Centre for Sleep Research, University of South Australia, Adelaide, SA, Australia Guido Grassi, Clinica Medica, San Gerardo Hospital, University of Milano Bicocca, Monza, Milan, Italy Wendell A. Grogan, Kingwood Neurology and Sleep, Kingwood, TX, USA Claudia Irene Gruttad’Auria, Dipartimento Biomedico di Medicina Interna e Specialistica (DiBiMIS), Università di Palermo, Palermo, Italy Zeynep Güne?, School of Health, Adnan Menderes University, Ayd?n, Turkey Ilana S. Hairston, School of Behavioral Sciences, Academic College of Tel Aviv-Jaffa, Tel Aviv, Israel Fahed Hakim Department of Immunology, Technion, Israel Institute of Technology, Haifa, Israel Rambam Health Care Campus, Haifa, Israel Ahmad O. Hammoud, M.P.H, University of Utah, Salt Lake City, UT, USA Hans-Ulrich Häring Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University of Tuebingen, Baden-Württemberg, Germany German Center for Diabetes Research (DZD), Tuebingen, Baden-Württemberg, Germany Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (IDM), Tuebingen, Baden-Württemberg, Germany Shelby Harris, Behavioral Sleep Medicine Program Sleep-Wake Disorder Center at the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA Ashfaq Hasan, Department of Pulmonary Medicine, Deccan College of Medical Sciences/Owaisi Hospital and Research Centre, Hyderabad, India Georgina Heath, Centre for Sleep Research, University of South Australia, Adelaide, SA, Australia Július Hodosy Institute of Molecular Biomedicine, Comenius University, Bratislava, Slovakia; Center for Molecular Medicine, Slovak Academy of Sciences, Bratislava, Slovakia Institute of Physiology, Comenius University, Bratislava, Slovakia Winni F. Hofman, Department of Psychology, Brain and Cognition Group, University of Amsterdam, Amsterdam, The Netherlands Heather E. Howe, University of Utah, Salt Lake City, UT, USA Helena Igelström, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden Yuichi Inoue, Department of Somnology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan Hiroyasu Iso, Public Health, Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Suita-City, Osaka, Japan Ashutosh Kaul, Department of Surgery, Westchester Medical Center, Valhalla, NY, USA Shannon R. Kenney, Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA William D.S. Killgore, Center for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA Yoko Komada, Department of Somnology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan B. Santhosh Kumar, Department of Pathology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India Nancy Linford, Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA António Macedo, Faculty of Medicine, Department of Psychological Medicine, University of Coimbra, Coimbra, Portugal Anthony Maffei, Department of Surgery, Westchester Medical Center, Valhalla, NY, USA Paul E. Marik, Division of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, VA, USA Anna Maria Marotta, Dipartimento Biomedico di Medicina Interna e Specialistica (DiBiMIS), Università di Palermo, Palermo, Italy Oreste Marrone, Istituto di Biomedicina e Immunologia Molecolare (IBIM), Consiglio Nazionale delle Ricerche (CNR), Palermo, Italy Nobuhide Matsuoka, Department of Surgery, Westchester Medical Center, Valhalla, NY,...